PMID: 6408330Jul 11, 1983Paper

Minireview. Thyrotropin releasing hormone and CNS cholinergic neurons

Life Sciences
G G Yarbrough

Abstract

The centrally mediated pharmacological effects of thyrotropin releasing hormone (TRH), their mechanistic basis and therapeutic implications, along with the possible physiological significance of extrahypothalamic TRH, have been the subject of numerous investigations for over a decade. Despite this effort a holistic perspective on these issues and considerations does not exist. However, with continued research employing multiple and diverse experimental approaches, many interactions of TRH and related peptides with central cholinergic mechanisms have been revealed. These interactions are documented in this review and it is proposed that they can account for several of the more prominent pharmacological actions of these peptides. Additionally, it is suggested that a function of endogenous YHR, throughout the neuroaxis, may be to regulate the excitability of central cholinergic neurons.

References

Jan 20, 1977·Nature·R A Nicoll
Feb 25, 1977·Brain Research·F C KardonR D Utiger
Jul 1, 1979·Endocrinology·A Melander, F Sundler
Apr 15, 1976·Psychopharmacologia·M D Stanes, C P Brown
Jul 19, 1974·Science·A Winokur, R D Utiger
Oct 15, 1974·Experientia·L Schenkel-HulligerL Maître
Jul 21, 1980·Brain Research·D J BraitmanD O Carpenter
Jun 1, 1980·Brain : a Journal of Neurology·A J RockelT P Powell

❮ Previous
Next ❯

Citations

Jan 1, 1991·Journal of Tongji Medical University = Tong Ji Yi Ke Da Xue Xue Bao·Z G Nie, Z Y Liu
Sep 1, 1988·Journal of Anesthesia·M MiyazakiT Mizobe
Apr 10, 1991·European Journal of Pharmacology·H UjiharaS Takaori
Jan 1, 1992·Pharmacology, Biochemistry, and Behavior·S A StwertkaA G Verderese
Mar 1, 1994·Pharmacology, Biochemistry, and Behavior·A KhanM H Mirolo
Jan 1, 1989·Brain Research. Brain Research Reviews·S M Gardiner, T Bennett
May 1, 1986·Peptides·J A TonnaerJ S De Graaf
Mar 1, 1987·Peptides·P D Butler, R J Bodnar
Sep 1, 1989·Neurobiology of Aging·L L Butcher, N J Woolf
Jan 1, 1985·Progress in Neuro-psychopharmacology & Biological Psychiatry·G G Yarbrough, N Pomara
Jul 1, 1997·Experimental Gerontology·G W BennettK C Fone
Jan 7, 1998·Bioorganic & Medicinal Chemistry·A A MazurovT A Voronina
Apr 21, 1999·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·K KashiharaT Shohmori
Dec 1, 1991·Alcoholism, Clinical and Experimental Research·J C GarbuttG A Mason
Jan 1, 1989·Annals of the New York Academy of Sciences·L O Koskinen
Apr 1, 1988·Annals of Emergency Medicine·R L MuellemanJ A Salomone
Aug 7, 2002·The Journal of Pharmacy and Pharmacology·Jiaxiang WuNicholas Bodor
Apr 1, 1995·Journal of Geriatric Psychiatry and Neurology·S V Patel
Apr 1, 1990·Experimental Neurology·K YamashitaS Otsuki
Feb 28, 2003·The Journal of Pharmacology and Experimental Therapeutics·Keith A GaryAndrew Winokur
Nov 13, 2019·Journal of Peptide Science : an Official Publication of the European Peptide Society·Naotake KobayashiTakayoshi Yoshikawa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.